Contribution of EAE to understanding and treating multiple sclerosis

被引:16
|
作者
Lovett-Racke, Amy E. [1 ]
机构
[1] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA
关键词
Experimental autoimmune encephalomyelitis; Multiple sclerosis; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; T-BET; DEMYELINATING DISEASE; LINEAGE COMMITMENT; ADOPTIVE TRANSFER; CELLS; LYMPHOCYTES; MICE;
D O I
10.1016/j.jneuroim.2016.08.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This article is a summary of a lecture presented at the 40 years of Neuroimmunology meeting held on April 19, 2015, in commemoration of the 40th anniversary of the Neuroimmunology Branch (NIB) at the National Institutes of Health. Experimental autoimmune encephalomyelitis (EAE) has been used as a model for multiple sclerosis (MS) for several decades. There are remarkable similarities between the central nervous system pathology of mice with EAE and MS patients. However, there are distinct differences which limits the contribution of EAE to the understanding of MS. My lecture summarized the role that the NIB played in establishing EAE as a valid model for studying MS, and the role that EAE has played in my own research. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:40 / 42
页数:3
相关论文
共 50 条
  • [21] Contribution of magnetic resonance imaging techniques in understanding cognitive impairment in multiple sclerosis
    M. Filippi
    The Italian Journal of Neurological Sciences, 1998, 19 : S399 - S402
  • [22] Contribution of magnetic resonance imaging techniques in understanding cognitive impairment in multiple sclerosis
    Filippi, M
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 19 (06): : S399 - S402
  • [23] Contribution to the histopathology of the multiple sclerosis
    Marinesco, G
    Minea, J
    REVUE NEUROLOGIQUE, 1909, 17 : 957 - 970
  • [24] Treating multiple sclerosis with vitamin D
    Chataway, Jeremy
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (05): : 473 - 473
  • [25] Oral Agents for Treating Multiple Sclerosis
    Khan, Seher A.
    US PHARMACIST, 2020, 45 (01) : HS2 - HS7
  • [26] Treating multiple Sclerosis by hemolytic Serotherapy
    Strauss
    NERVENARZT, 1931, 4 (01): : 63 - 63
  • [27] Towards Treating Multiple Sclerosis Progression
    Haeusler, Darius
    Weber, Martin S.
    PHARMACEUTICALS, 2024, 17 (11)
  • [28] Th9 cells in the pathogenesis of EAE and multiple sclerosis
    Wassim Elyaman
    Samia J. Khoury
    Seminars in Immunopathology, 2017, 39 : 79 - 87
  • [29] Towards treating progressive multiple sclerosis
    Alan Thompson
    Olga Ciccarelli
    Nature Reviews Neurology, 2020, 16 : 589 - 590
  • [30] Treating multiple sclerosis with generic cladribine
    Alvarez-Gonzalez, C.
    Allen-Philbey, K.
    Mathews, J.
    Espasandin, M.
    Turner, B. P.
    Gnanapavan, S.
    Marta, M.
    Giovannoni, G.
    Baker, D.
    Schmierer, K.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 604 - 605